Related Experiment Videos

[Hemolytic-uremic syndrome and Campylobacter jejuni enteritis]

A Lacaille, F Hilpert, P Fouet

Presse Medicale (Paris, France : 1983)

|October 5, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients.

ESMO open·2021

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS).

Gynecologic oncology·2019

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

See all related articles